课题基金 / 基金详情

PHASE II RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED SAFETY AND PHARMACOKINETIC

PHASE II RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED SAFETY AND PHARMACOKINETIC
II 期随机、双盲、安慰剂对照安全性和药代动力学
批准号：
7716605
负责人：
KRISTI L. WATTERBERG
金额：
$0.83万
依托单位：
UNIVERSITY OF NEW MEXICO
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-05-01 至 2008-11-30
来源：
https://reporter.nih.gov/project-details/7716605
关键词：
BirthComputer Retrieval of Information on Scientific Projects DatabaseDoseDouble-Blind MethodDrug KineticsFundingGrantInfantInositolInstitutionIntravenousPhasePlacebo ControlPregnancyPurposeRandomizedResearchResearch PersonnelResourcesSafetySourceUnited States National Institutes of Healthrenal tubular reabsorption

项目摘要

项目成果

KRISTI L. WATTERBERG的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is: a. Determine the single-dose pharmacokinetics of intravenous inositol given at a dose of either 60 or 120 mg/kg soon after birth to extremely low gestation infants. b. Determine whether the pharmacokinetics of inositol are linar or nonlinear and determine whether nonlinearity may be related to saturable renal tubular reabsorption.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adrenal function and adverse CV outcomes at age 6 after extremely preterm birth
Adrenal function and adverse CV outcomes at age 6 after extremely preterm birth
Adrenal function and adverse CV outcomes at age 6 after extremely preterm birth
NEUROIMAGING AND NEURODEVELOPMENTAL OUTCOME: A SECONDARY TO SURFACTANT
  • 批准号：
    8166608
  • 项目类别：
  • 资助金额：
    $0.09万
  • 财政年份：
    2009
  • 负责人：
    KRISTI L. WATTERBERG
  • 依托单位：
    UNIVERSITY OF NEW MEXICO